Roche pursues partnering approach in shifting Asian landscape
This article was originally published in Scrip
Roche expects to do its biggest ever number of licensing and technology deals in 2008. But despite the figure, which will approach 50, "we are staying firmly focused on first-in-class innovation and medically differentiated products", maintains Dan Zabrowski, the company's global head of pharma partnering.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.